Increased levels of matrix metalloproteinase‐9 and interleukin‐8 in blister fluids of dystrophic and junctional epidermolysis bullosa patients-Reference-Cited by-同舟云学术

Increased levels of matrix metalloproteinase‐9 and interleukin‐8 in blister fluids of dystrophic and junctional epidermolysis bullosa patients

Published:2014-02-17 Issue:2 Volume:29 Page:396-398
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Lettner T.¹,Lang R.²,Bauer J.W.¹²,Wally V.¹

Affiliation:

1. Division of Experimental Dermatology and EB House Austria Department of Dermatology University Hospital Salzburg Paracelsus Medical University Salzburg Austria

2. Department of Dermatology University Hospital Salzburg Paracelsus Medical University Salzburg Austria

Funder

DEBRA

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.12399

Reference10 articles.

1. MMP-9 and CXCL8/IL-8 Are Potential Therapeutic Targets in Epidermolysis Bullosa Simplex

2. The specific proteolysis hypothesis of pemphigus: Does the song remain the same?

3. Defining the involvement of proteinases in pemphigus vulgaris: Evidence of matrix metalloproteinase-9 overexpression in experimental models of disease

4. A major role for neutrophils in experimental bullous pemphigoid.

5. Two Familial Cases of Epidermolysis Bullosa Simplex Successfully Treated With Tetracycline

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of junctional epidermolysis bullosa intermediate with collagen XVII deficiency treated with dupilumab;Journal of Dermatological Treatment;2023-11-15

2. Impact of low-dose calcipotriol ointment on wound healing, pruritus and pain in patients with dystrophic epidermolysis bullosa: A randomized, double-blind, placebo-controlled trial;Orphanet Journal of Rare Diseases;2021-11-08

3. Immunological mechanisms underlying progression of chronic wounds in recessive dystrophic epidermolysis bullosa;Experimental Dermatology;2021-06-27

4. Diversity of Mechanisms Underlying Latent TGF-β Activation in Recessive Dystrophic Epidermolysis Bullosa;Journal of Investigative Dermatology;2021-06

5. A Review of Acquired Autoimmune Blistering Diseases in Inherited Epidermolysis Bullosa: Implications for the Future of Gene Therapy;Antibodies;2021-05-17